1. Home
  2. CERS vs LXFR Comparison

CERS vs LXFR Comparison

Compare CERS & LXFR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CERS
  • LXFR
  • Stock Information
  • Founded
  • CERS 1991
  • LXFR 1898
  • Country
  • CERS United States
  • LXFR United States
  • Employees
  • CERS N/A
  • LXFR N/A
  • Industry
  • CERS EDP Services
  • LXFR Major Chemicals
  • Sector
  • CERS Technology
  • LXFR Industrials
  • Exchange
  • CERS Nasdaq
  • LXFR Nasdaq
  • Market Cap
  • CERS 347.3M
  • LXFR 380.9M
  • IPO Year
  • CERS 1997
  • LXFR 2012
  • Fundamental
  • Price
  • CERS $1.65
  • LXFR $14.17
  • Analyst Decision
  • CERS Buy
  • LXFR
  • Analyst Count
  • CERS 3
  • LXFR 0
  • Target Price
  • CERS $3.17
  • LXFR N/A
  • AVG Volume (30 Days)
  • CERS 1.6M
  • LXFR 127.9K
  • Earning Date
  • CERS 02-20-2025
  • LXFR 02-25-2025
  • Dividend Yield
  • CERS N/A
  • LXFR 3.67%
  • EPS Growth
  • CERS N/A
  • LXFR 57.96
  • EPS
  • CERS N/A
  • LXFR 0.34
  • Revenue
  • CERS $180,270,000.00
  • LXFR $384,400,000.00
  • Revenue This Year
  • CERS $15.95
  • LXFR N/A
  • Revenue Next Year
  • CERS $10.50
  • LXFR $3.44
  • P/E Ratio
  • CERS N/A
  • LXFR $44.72
  • Revenue Growth
  • CERS 15.29
  • LXFR N/A
  • 52 Week Low
  • CERS $1.38
  • LXFR $7.61
  • 52 Week High
  • CERS $2.59
  • LXFR $15.64
  • Technical
  • Relative Strength Index (RSI)
  • CERS 41.40
  • LXFR 51.57
  • Support Level
  • CERS $1.64
  • LXFR $14.11
  • Resistance Level
  • CERS $1.96
  • LXFR $14.71
  • Average True Range (ATR)
  • CERS 0.11
  • LXFR 0.41
  • MACD
  • CERS -0.02
  • LXFR -0.01
  • Stochastic Oscillator
  • CERS 3.12
  • LXFR 48.03

About CERS Cerus Corporation

Cerus Corp is a biomedical products company focused on the field of blood transfusion safety. The INTERCEPT Blood System is designed to reduce the risk of transfusion-transmitted infections by inactivating a broad range of pathogens such as viruses, bacteria, and parasites. The company sells its INTERCEPT platelet and plasma systems in the United States of America, Europe, the Commonwealth of Independent States countries, the Middle East, and selected countries in other regions around the world. The firm continues to operate in only one segment: Blood safety and generates revenue from the same.

About LXFR Luxfer Holdings PLC

Luxfer Holdings PLC is a manufacturer industrial company innovating niche applications in materials engineering. It focuses on value creation by using its broad array of technical know-how and proprietary technologies to help create a safe, clean, and energy-efficient world. Luxfer's high-performance materials, components, and high-pressure gas containment devices are used in defense, first response and healthcare, transportation, and general industrial applications. It focuses on product lines related to magnesium alloys, zirconium chemicals, and carbon composites. Its segments are Elektron, Gas Cylinders, and Graphic Arts. It generates the majority of its revenue from Elektron and as well as Gas Cylinders.

Share on Social Networks: